Predict your next investment

Illumicare company logo
SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
illumicare.com

See what CB Insights has to offer

Total Raised

$6.56M

Investors Count

2

Illumicare Funding, Illumicare Valuation & Illumicare Revenue

4 Fundings

Illumicare's latest funding round was a Loan for $0.68M on April 9, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/9/2020

Loan

$0.68M

$0.00B

((9.99x))

FY 1234

7/20/2017

Unattributed - II

$99M

$0.00B

((9.99x))

FY 1234

10

3/22/2016

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

12/31/2015

Grant

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/9/2020

7/20/2017

3/22/2016

12/31/2015

Round

Loan

Unattributed - II

Unattributed

Grant

Amount

$0.68M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

10

10

10

Illumicare Investors

2 Investors

Illumicare has 2 investors. Paycheck Protection Program invested in Illumicare's Loan funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/9/2020

4/9/2020

1
Loan

Government

DC

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Incubator/Accelerator

Alabama

First funding

4/9/2020

00/00/0000

Last Funding

4/9/2020

00/00/0000

Investor

Subscribe to see more

Rounds

1
Loan

Subscribe to see more

Board Seats

Subscribe to see more

Type

Government

Incubator/Accelerator

Location

DC

Alabama

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.